Biblio

Author Title [ Type

] Year

Filters: Author is Jiang, Hao [Clear All Filters]

Journal Article

Sun K, Wang J, Wang Y-Z, Shi Z-Y, Chang Y, Yuan X-Y, Liu Y-R, Jiang H, Jiang Q, Huang X-J, et al. Prognostic significance of the frequencies of bone marrow lymphocyte subsets in adult acute myeloid leukemia at diagnosis. Int J Lab Hematol. 2023.

Jiang H, Liu J, Song Y, Lei J. Quantitative Modeling of Stemness in Single-Cell RNA Sequencing Data: A Nonlinear One-Class Support Vector Machine Method. J Comput Biol. 2023.

Wu Y-J, Hou M, Liu H-X, Peng J, Ma L-M, Yang L-H, Feng R, Liu H, Liu Y, Feng J, et al. A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data. Blood Adv. 2020;4(22):5846-5857.

Zhao P, Hou M, Liu Y, Liu H-X, Bin Huang R-, Yao H-X, Niu T, Peng J, Jiang M, Han Y-Q, et al. Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age. Platelets. 2020:1-9.

Wang Y-Z, Hao L, Chang Y, Jiang Q, Jiang H, Zhang L-P, He L-L, Yuan X-Y, Qin Y-Z, Huang X-J, et al. A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype. Leuk Res. 2018;72:12-19.

Yu W-J, Wu Y, Liu J, Chen Y, Hou R-Q, Huang X-J, Jiang H. Successful management of a high-risk acute myeloid leukemia patient with severe coronary heart disease by venetoclax plus azacytidine and coronary artery bypass grafting. J Transl Int Med. 2024;12(1):119-122.

Zhou Y, Liu W, Jiang H, Chen F, Li Y, Gardea-Torresdey JL, Zhou X-X, Yan B. Surface-Charge-Driven Ferroptosis and Mitochondrial Dysfunction Is Involved in Toxicity Diversity in the Marine Bivalve Exposed to Nanoplastics. ACS Nano. 2024.

Pan X'an, Chang Y, Ruan G, Zhou S, Jiang H, Jiang Q, Huang X, Zhao X-S. TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database. Clin Exp Med. 2024;24(1):35.

Sun Y, Wang X, Chen W-M, Hao Y, Di Li L-, Li J-Y, Sun K, Shi Z-Y, Jiang H, Jiang Q, et al. Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia. Hematol Oncol. 2024;42(2):e3264.

Pages